As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.

WeightWatchers filed for bankruptcy to try to reduce debt as it expands its telehealth business. In this photo illustration, ...

For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...

GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...

Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing ...

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...